BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 19180143)

  • 1. M-PEIs nanogels: potential nonviral vector for systemic plasmid delivery to tumor cells.
    Dong L; Xu H; Liu YB; Lu B; Xu DM; Li BH; Gao J; Wu M; Yao SD; Zhao J; Guo YJ
    Cancer Gene Ther; 2009 Jul; 16(7):561-6. PubMed ID: 19180143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Size-dependent properties of M-PEIs nanogels for gene delivery in cancer cells.
    Xu DM; Yao SD; Liu YB; Sheng KL; Hong J; Gong PJ; Dong L
    Int J Pharm; 2007 Jun; 338(1-2):291-6. PubMed ID: 17367967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of a star-shaped copolymer as a vector for FGF receptor-mediated gene delivery in vitro and in vivo.
    Li D; Ping Y; Xu F; Yu H; Pan H; Huang H; Wang Q; Tang G; Li J
    Biomacromolecules; 2010 Sep; 11(9):2221-9. PubMed ID: 20704346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene therapy of neural cell injuries in vitro using the hypoxia-inducible GM-CSF expression plasmids and water-soluble lipopolymer (WSLP).
    Kim JM; Lee M; Kim KH; Ha Y; Choi JK; Park SR; Park H; Park HC; Ahn CH; Kim SW; Choi BH
    J Control Release; 2009 Jan; 133(1):60-7. PubMed ID: 18938203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific systemic nonviral gene delivery to human hepatocellular carcinoma xenografts in SCID mice.
    Wolschek MF; Thallinger C; Kursa M; Rössler V; Allen M; Lichtenberger C; Kircheis R; Lucas T; Willheim M; Reinisch W; Gangl A; Wagner E; Jansen B
    Hepatology; 2002 Nov; 36(5):1106-14. PubMed ID: 12395320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient therapeutic gene delivery after systemic administration of a novel polyethylenimine/DNA vector in an orthotopic bladder cancer model.
    Sweeney P; Karashima T; Ishikura H; Wiehle S; Yamashita M; Benedict WF; Cristiano RJ; Dinney CP
    Cancer Res; 2003 Jul; 63(14):4017-20. PubMed ID: 12874000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective gene transfer to solid tumors using different nonviral gene delivery techniques: electroporation, liposomes, and integrin-targeted vector.
    Cemazar M; Sersa G; Wilson J; Tozer GM; Hart SL; Grosel A; Dachs GU
    Cancer Gene Ther; 2002 Apr; 9(4):399-406. PubMed ID: 11960291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo gene delivery in the mouse lung with lactosylated polyethylenimine, questioning the relevance of in vitro experiments.
    Grosse S; Thévenot G; Aron Y; Duverger E; Abdelkarim M; Roche AC; Monsigny M; Fajac I
    J Control Release; 2008 Dec; 132(2):105-12. PubMed ID: 18801395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative comparison of polyethylenimine formulations and adenoviral vectors in terms of intracellular gene delivery processes.
    Varga CM; Tedford NC; Thomas M; Klibanov AM; Griffith LG; Lauffenburger DA
    Gene Ther; 2005 Jul; 12(13):1023-32. PubMed ID: 15815703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High mobility group box 1 protein enhances polyethylenimine mediated gene delivery in vitro.
    Shen Y; Peng H; Deng J; Wen Y; Luo X; Pan S; Wu C; Feng M
    Int J Pharm; 2009 Jun; 375(1-2):140-7. PubMed ID: 19442462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polycation nanostructured lipid carrier, a novel nonviral vector constructed with triolein for efficient gene delivery.
    Zhang Z; Sha X; Shen A; Wang Y; Sun Z; Gu Z; Fang X
    Biochem Biophys Res Commun; 2008 Jun; 370(3):478-82. PubMed ID: 18395002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene delivery to the lung using protein/polyethylenimine/plasmid complexes.
    Orson FM; Song L; Gautam A; Densmore CL; Bhogal BS; Kinsey BM
    Gene Ther; 2002 Apr; 9(7):463-71. PubMed ID: 11938461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective tumor targeted gene transfer using PEGylated adenovirus vector via systemic administration.
    Gao JQ; Eto Y; Yoshioka Y; Sekiguchi F; Kurachi S; Morishige T; Yao X; Watanabe H; Asavatanabodee R; Sakurai F; Mizuguchi H; Okada Y; Mukai Y; Tsutsumi Y; Mayumi T; Okada N; Nakagawa S
    J Control Release; 2007 Sep; 122(1):102-10. PubMed ID: 17628160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A biodegradable low molecular weight polyethylenimine derivative as low toxicity and efficient gene vector.
    Wen Y; Pan S; Luo X; Zhang X; Zhang W; Feng M
    Bioconjug Chem; 2009 Feb; 20(2):322-32. PubMed ID: 19152330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delivery of polyethylenimine/DNA complexes assembled in a microfluidics device.
    Koh CG; Kang X; Xie Y; Fei Z; Guan J; Yu B; Zhang X; Lee LJ
    Mol Pharm; 2009; 6(5):1333-42. PubMed ID: 19552481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravascular administration of tumor tropic neural progenitor cells permits targeted delivery of interferon-beta and restricts tumor growth in a murine model of disseminated neuroblastoma.
    Dickson PV; Hamner JB; Burger RA; Garcia E; Ouma AA; Kim SU; Ng CY; Gray JT; Aboody KS; Danks MK; Davidoff AM
    J Pediatr Surg; 2007 Jan; 42(1):48-53. PubMed ID: 17208540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient inhibition of C-26 colon carcinoma by VSVMP gene delivered by biodegradable cationic nanogel derived from polyethyleneimine.
    Gou M; Men K; Zhang J; Li Y; Song J; Luo S; Shi H; Wen Y; Guo G; Huang M; Zhao X; Qian Z; Wei Y
    ACS Nano; 2010 Oct; 4(10):5573-84. PubMed ID: 20839784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of folate-PEG-grafted-hybranched-PEI nonviral vector for the inhibition of glioma growth in the rat.
    Liang B; He ML; Chan CY; Chen YC; Li XP; Li Y; Zheng D; Lin MC; Kung HF; Shuai XT; Peng Y
    Biomaterials; 2009 Aug; 30(23-24):4014-20. PubMed ID: 19427690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiangiogenic gene therapy with systemically administered sFlt-1 plasmid DNA in engineered gelatin-based nanovectors.
    Kommareddy S; Amiji M
    Cancer Gene Ther; 2007 May; 14(5):488-98. PubMed ID: 17363959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic anticancer gene medicine exploits intrinsic antitumor activity of cationic vector to cure established tumors.
    Dufès C; Keith WN; Bilsland A; Proutski I; Uchegbu IF; Schätzlein AG
    Cancer Res; 2005 Sep; 65(18):8079-84. PubMed ID: 16166279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.